Debt-to-equity of LIFECORE BIOMEDICAL, INC. \DE\ from 26 Feb 2012 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
LIFECORE BIOMEDICAL, INC. \DE\ quarterly Debt-to-equity in % history and change rate from 26 Feb 2012 to 30 Sep 2025.
  • LIFECORE BIOMEDICAL, INC. \DE\ Debt-to-equity for the quarter ending 30 Sep 2025 was 12360%, a 310% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

LIFECORE BIOMEDICAL, INC. \DE\ Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 12360% +9348% +310% 30 Sep 2025
Q2 2025 6097% +1296% +27% 25 May 2025
Q1 2025 3166% -59689% -95% 23 Feb 2025
Q4 2024 1950% -2361% -55% 24 Nov 2024
Q3 2024 3012% +2101% +230% 25 Aug 2024
Q2 2024 4800% +4369% +1014% 26 May 2024
Q1 2024 62855% +62582% +22889% 25 Feb 2024
Q4 2023 4311% +4110% +2047% 26 Nov 2023
Q3 2023 911% +734% +414% 27 Aug 2023
Q2 2023 431% +278% +182% 28 May 2023
Q1 2023 273% +129% +90% 26 Feb 2023
Q4 2022 201% +52% +35% 27 Nov 2022
Q3 2022 177% +35% +25% 28 Aug 2022
Q2 2022 153% +11% +7.8% 29 May 2022
Q1 2022 144% +5.6% +4.1% 27 Feb 2022
Q4 2021 149% +18% +14% 28 Nov 2021
Q3 2021 142% +17% +13% 29 Aug 2021
Q2 2021 142% +23% +19% 30 May 2021
Q1 2021 139% +30% +27% 28 Feb 2021
Q4 2020 131% +31% +32% 29 Nov 2020
Q3 2020 125% +39% +44% 30 Aug 2020
Q2 2020 119% +44% +59% 31 May 2020
Q1 2020 109% +42% +62% 23 Feb 2020
Q4 2019 100% +41% +69% 24 Nov 2019
Q3 2019 87% +28% +47% 25 Aug 2019
Q2 2019 75% +16% +27% 26 May 2019
Q1 2019 67% +8.5% +15% 24 Feb 2019
Q4 2018 59% +0.28% +0.48% 25 Nov 2018
Q3 2018 59% +2.4% +4.1% 26 Aug 2018
Q2 2018 59% +2.5% +4.4% 27 May 2018
Q1 2018 59% +0.81% +1.4% 25 Feb 2018
Q4 2017 59% -0.23% -0.39% 26 Nov 2017
Q3 2017 57% -3.1% -5.2% 27 Aug 2017
Q2 2017 57% -1.8% -3% 28 May 2017
Q1 2017 58% +0.22% +0.38% 26 Feb 2017
Q4 2016 59% +1.7% +2.9% 27 Nov 2016
Q3 2016 60% +2.2% +3.7% 28 Aug 2016
Q2 2016 59% -0.39% -0.66% 29 May 2016
Q1 2016 58% -0.35% -0.6% 28 Feb 2016
Q4 2015 57% +0.42% +0.74% 29 Nov 2015
Q3 2015 58% +1.7% +3.1% 30 Aug 2015
Q2 2015 59% +2.9% +5.2% 31 May 2015
Q1 2015 58% -0.15% -0.26% 01 Mar 2015
Q4 2014 57% -3.4% -5.6% 30 Nov 2014
Q3 2014 56% -5.8% -9.4% 31 Aug 2014
Q2 2014 56% -9.8% -15% 25 May 2014
Q1 2014 58% -13% -18% 23 Feb 2014
Q4 2013 60% -6.4% -9.6% 24 Nov 2013
Q3 2013 62% -0.21% -0.34% 25 Aug 2013
Q2 2013 66% +10% +18% 26 May 2013
Q1 2013 71% +24% +52% 24 Feb 2013
Q4 2012 67% 25 Nov 2012
Q3 2012 62% 26 Aug 2012
Q2 2012 56% 27 May 2012
Q1 2012 47% 26 Feb 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.